WHO ends hydroxychloroquine trial for COVID-19
PTI, Jul 5, 2020, 9:24 AM IST
Representative image
Berlin: The World Health Organization says it is ending a trial into whether anti-malarial drug hydroxychloroquine helps patients hospitalized with COVID-19.
WHO said Saturday it has “accepted the recommendation” from the committee overseeing the trial to discontinue testing of hydroxychloroquine and lopinavir/ritonavir, a drug combination used to treat HIV/AIDS. The drugs were being compared with standard care for hospitalized patients.
WHO says a review of the interim results showed hydroxychloroquine and lopinavir/ritonavir “produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care.”
The agency adds that while there was no “solid evidence” of increased mortality for hospitalized patients given the drugs, there were “some associated safety signals in the clinical laboratory findings” of an associated trial.
WHO says the decision won’t affect possible trials on patients who aren’t hospitalized, or on those receiving the drugs before potential exposure to the coronavirus or shortly afterward.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
MUST WATCH
Latest Additions
Phenomenal Pant plots India’s fight back with game-changing ton on day 1
HD Kumaraswamy predicts possibility of early Assembly polls in Karnataka
PM Modi and Russian President Putin discuss state of global energy & food markets
Senior Congress leader draws flak for remark on former PM Deve Gowda
Stolen 17th century Tamil bible traced to London after 17 years